Small Caps Today
Stock Market Today: S&P 500 Eyes Record High as Trade Deal Hopes and Rate Cut Bets Drive Stock Gains
Jun 27, 2025

Stock Market Today: S&P 500 Eyes Record High as Trade Deal Hopes and Rate Cut Bets Drive Stock Gains

4' read
GMS Becomes The Center Of A $5 Billion Tug-Of-War — Here’s Why Everyone Wants In!
Jun 27, 2025

GMS Becomes The Center Of A $5 Billion Tug-Of-War — Here’s Why Everyone Wants In!

7' read
Jun 27, 2025

Google’s Rough 2025 Could Be Setting the Stage for a Comeback

2025 has been a challenging year so far for Alphabet (GOOG, GOOGL), with the stock down about 9% year-to-date.

3' read
Micron Rises on Strong Earnings, But AI Growth Expectations Keep Investors Cautious
Jun 26, 2025

Micron Rises on Strong Earnings, But AI Growth Expectations Keep Investors Cautious

5' read
Stock Market Today: Market Rally Continues as Investor Optimism Picks Up
Jun 26, 2025

Stock Market Today: Market Rally Continues as Investor Optimism Picks Up

5' read
Caterpillar Isn’t Just About Bulldozers Anymore—It’s Fueling Data Centers!
Jun 26, 2025

Caterpillar Isn’t Just About Bulldozers Anymore—It’s Fueling Data Centers!

7' read
Microsoft on the Brink: What a Split With OpenAI Means for the Future of AI!
Jun 26, 2025

Microsoft on the Brink: What a Split With OpenAI Means for the Future of AI!

7' read
Peloton’s Bold Reset: Can New Hires & Smarter Spending Power A Comeback?
Jun 25, 2025

Peloton’s Bold Reset: Can New Hires & Smarter Spending Power A Comeback?

8' read
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
Jun 25, 2025

Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!

8' read

Business & Market Movers

Google’s Rough 2025 Could Be Setting the Stage for a Comeback

Stock Market Today: S&P 500 Eyes Record High as Trade Deal Hopes and Rate Cut Bets Drive Stock Gains

Stock Market Today: S&P 500 Eyes Record High as Trade Deal Hopes and Rate Cut Bets Drive Stock Gains

·Jun 27, 2025
GMS Becomes The Center Of A $5 Billion Tug-Of-War — Here’s Why Everyone Wants In!

GMS Becomes The Center Of A $5 Billion Tug-Of-War — Here’s Why Everyone Wants In!

·Jun 27, 2025
Micron Rises on Strong Earnings, But AI Growth Expectations Keep Investors Cautious

Micron Rises on Strong Earnings, But AI Growth Expectations Keep Investors Cautious

·Jun 26, 2025
Stock Market Today: Market Rally Continues as Investor Optimism Picks Up

Stock Market Today: Market Rally Continues as Investor Optimism Picks Up

·Jun 26, 2025

Caterpillar Isn’t Just About Bulldozers Anymore—It’s Fueling Data Centers!

Breaking News

s
scdadmin
·Jan 30, 2024

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.

3' read
Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

scdadmin·Jan 30, 2024
Stock Market Today: Mixed Signals Keep Stocks Muted

Stock Market Today: Mixed Signals Keep Stocks Muted

scdadmin·Jan 04, 2024
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

scdadmin·Dec 15, 2023
COP28 Reshapes Oil: Navigating Energy Transition

COP28 Reshapes Oil: Navigating Energy Transition

scdadmin·Dec 14, 2023

Healthcare & Biotech

Jun 25, 2025

Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!

Eli Lilly has expanded into cardiovascular treatment with its $1.3 billion acquisition of Verve Therapeutics, a clinical-stage gene-editing company focused on one-time therapies to lower cholesterol and prevent heart disease.

8' read
SUPPER CHANGE YOUR PLANNING POWERS

Join our newsletter

Read and share new perspectives on just about any topic. Everyone’s welcome.
  • 01Create a free account
  • 02Write your story

Tech & Energy

Jun 27, 2025

Google’s Rough 2025 Could Be Setting the Stage for a Comeback

2025 has been a challenging year so far for Alphabet (GOOG, GOOGL), with the stock down about 9% year-to-date.

3' read